Home About Us Services Markets Online Trading Back Office Contact Us Download Mutual Fund
Vivanza Biosciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
 BSE Code
 530057
ISIN Demat
INE984E01035
Book Value
1.2368
Mar.Cap(Rs.Cr)
8.48
P/E
0.00
Face Value
1
Go
Your are on :   Markets   |  Company Profile   |  Key Financial Ratios
   YearsMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Debt-Equity Ratio1.081.330.640.050.16
Long Term Debt-Equity Ratio0.080.000.000.000.00
Current Ratio1.181.121.151.121.11
Fixed Assets360.25710.50457.50922.000.00
Inventory8.457.406.9614.756.83
Debtors1.281.461.361.471.58
Interest Cover Ratio2.022.602.071.320.55
PBIDTM (%)5.977.889.846.832.55
PBITM (%)5.907.889.736.722.55
PBDTM (%)3.054.865.141.74-2.12
CPM (%)2.294.015.141.19-2.12
APATM (%)2.224.015.031.08-2.12
ROCE (%)8.9811.5614.1316.250.00
RONW (%)7.0213.5711.502.750.00
Product Disclaimer Mandatory Information Privacy Policy Careers Risk disclosures Feedback Scores 2.0
Investor Charter
STOCK BROKER DEPOSITORY PARTICIPANTS INVESTOR GRIEVANCES ESCALATION MATRIX
Member Bank Details
"Investor Grievance" Mail your Grievance to info@lalkar.in
Important Links:   SEBI  |  NSE  |  BSE  |  MCX-SX  |  MCX   |   NCDEX  |  NSDL  |  CDSL  |  FMC   |   CDSL E-Voting  |  SMART ODR|  Saa₹thi  |  View Client Collateral Details  |  
Vernacular Languages  |  Online Freezing/Blocking Account  |  Advisory for Investor
SEBI REGISTRATION NOS - BSE CASH: INZ000269434  |  BSE FNO: INZ000269434  |  NSE CASH: INZ000269434  |  NSE FNO: INZ000269434  |  NSE CD: INZ000269434  |  MSEI CASH: INZ000269434   |   MSEI FNO: INZ000269434   |   MSEI CD: INZ000269434
AMFI NO : ARN- 19226
2010 © Lalkar Group. All rights reserved Designed, developed & powered by CMOTS Infotech(ISO 9001:2015 certified)